Shorter tuberculosis treatment for people without symptoms
Part of Infections clinical trials.
This trial tests a shorter treatment regimen for people with tuberculosis (TB) who don't have symptoms. If you have TB bacteria in your lungs but no cough, fever, night sweats, or weight loss, this study may offer a more convenient treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 14 and 80 years old
- You have TB bacteria confirmed in a sample from your lungs (sputum, lung fluid, or tissue)
- You have not had TB symptoms (like cough for more than 2 weeks, night sweats, fever, or weight loss) in the past 3 months
- You have not been treated for TB for more than 1 week in the last 6 months
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use effective birth control
- You do not have severe liver disease, low blood counts, or certain drug-resistant TB
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter treatment for children with tuberculosis (TB) that is not drug-resistant. It aims to find out if a shorter regimen works as well as the standard longer one, making treatment easier for children and their families.
This study tests if a shorter course of tuberculosis (TB) medicine works as well as the current longer treatment for children. If successful, it means fewer days of medicine and fewer side effects for kids.
This trial tests a new, all-oral, shorter treatment regimen for tuberculosis that is resistant to rifampicin, a key antibiotic. It may offer a more convenient and effective option for patients with this difficult-to-treat infection.
This study tests different treatment plans for people with tuberculosis (TB) that can be cured with standard medicines. It aims to find the best treatment for each person based on their risk score, which may lead to shorter or more effective treatment.
This study tests shorter treatment plans for tuberculosis (TB) in Kazakhstan. It aims to see if a newer drug combination can cure TB or TB infection faster and with fewer side effects.
This study tests whether a shorter course of TB treatment (4 months) works just as well as the standard longer course (6 months) for people whose chest X-ray suggests TB but whose sputum test does not confirm it. It aims to reduce treatment burden while keeping the cure rate high.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.